Background
Methods
Study population
Socio-demographic data
Cervical papanicolaou cytology
HPV DNA PCR and HPV genotyping
Ethical aspects
Statistical analysis
Results
Socio-demographic data
Cervical papanicolaou cytology
Cytological diagnosis | SSa
| IMSSb
| IICc
| Total | p value | ||||
---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | ||
Low-grade intraepithelial lesion | 6 | 3.6 | 0 | 0 | 1 | 0.6 | 7 | 1.4 | NSd
|
High-grade intraepithelial lesion | 1 | 0.6 | 2 | 1.2 | 0 | 0 | 3 | 0.6 | NS |
Invasive carcinoma | 0 | 0 | 1 | 0.6 | 0 | 0 | 1 | 0.2 | NS |
Total | 7 | 4.2 | 3 | 1.8 | 1 | 0.6 | 11 | 2.2 | 0.021 |
HPV DNA PCR and HPV genotyping
HPV PCR | SSa
| IMSSb
| IICc
| Total | p value | ||||
---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | ||
Positive | 18 | 10.8 | 2 | 1.2 | 4 | 2.4 | 24 | 4.8 | 0.001 |
Negative | 148 | 89.2 | 164 | 98.8 | 162 | 97.6 | 474 | 95.2 | NSd
|
Total | 166 | 100 | 166 | 100 | 166 | 100 | 498 | 100 |
HPV genotype | SSa
| IMSSb
| IICc
| Total |
p value | ||||
---|---|---|---|---|---|---|---|---|---|
No. | Proportion | No. | Proportion | No. | Proportion | No. | Proportion | ||
16 | 10 | 0.556 | 2 | 1 | 4 | 1 | 16 | 0.667 | |
16 and 18 | 2 | 0.111 | 0 | 0 | 0 | 0 | 2 | 0.83 | |
Negative for HPV 16, 18 and 33 | 6 | 0.333 | 0 | 0 | 0 | 0 | 6 | 0.25 | NSd
|
Total | 18 | 0.75 | 2 | 0.83 | 4 | 0.167 | 24 | 1 |
HPV genotype | LSILa
| HSILb
| ICc
| Total |
p value | ||||
---|---|---|---|---|---|---|---|---|---|
No. | Proportion | No. | Proportion | No. | Proportion | No. | Proportion | ||
16 | 2 | 0.286 | 2 | 0.667 | 1 | 1 | 5 | 0.454 | NSd
|
16 and 18 | 1 | 142 | 1 | 0.333 | 0 | 0 | 2 | 0.182 | NSd
|
33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NSd
|
PCR positive but negative for genotyping | 2 | 0.286 | 0 | 0 | 0 | 0 | 2 | 0.182 | NSd
|
PCR negative | 2 | 0.286 | 0 | 0 | 0 | 0 | 2 | 0.182 | NSd
|
Total | 7 | 0.636 | 3 | 0.273 | 1 | 0.91 | 11 | 1 | 0.021 |